Malaria Vaccine Booster Study
Malaria Prevention in Children
Sponsor GSK
4,500 Enrollment Target
25 Trial Sites
5 Countries
June 2028 Est. Completion
About This Trial
Evaluating optimal booster schedules for sustained malaria protection in endemic regions.
Primary Endpoints
- Clinical malaria incidence
- Antibody persistence
Latest Update
January 2026
WHO prequalification received. Over 18 million doses shipped to endemic countries.